✉news BusinessLabor first seen 5 h ago, last 1 h ago, peak #22

Novartis signs up to $7.8 billion mRNA deal with China's Abogen

Original: Novartis strikes up to $7.8 billion mRNA deal with China's Abogen

Swiss pharmaceutical company Novartis has struck a deal worth up to $7.8 billion with China's Abogen Biosciences covering mRNA-based therapies, according to Reuters. The agreement highlights growing Western interest in Chinese biotech and in mRNA platforms beyond vaccines. Analysts are likely to weigh what the deal means for Novartis's pipeline and for China's expanding life sciences sector.

Why now: A large cross-border pharma licensing deal signals the rising value of Chinese biotech and mRNA technology.

NovartisAbogen BiosciencesChinaSwitzerland

Open on news →

Rank over time, top of the chart is #1. 4 snapshots from 5 h ago to 1 h ago.

Evidence

• Novartis strikes up to $7.8 billion mRNA deal with China's Abogen · Reuters

API: https://socialmediatrends-api.osmike.com/v1/trends/728004